Blood Pressure Medication Recalled: More Than 580,000 Bottles Affected

Capsules have impurity levels that exceed safety limits

AARP

Comments

Published October 31, 2025

blood pressure pills spilling out of bottle

AARP (Getty Images)

This article used AI tools to compile recall data. An AARP editor reviewed and refined the content for accuracy and clarity.

Two pharmaceutical companies have issued voluntary nationwide recalls of prazosin hydrochloride capsules because the pills contain an impurity in amounts that exceed the acceptable safety limit, according to the Food and Drug Administration (FDA).

The agency cited “failed impurities/degradation specification” as the reason for the recalls, meaning the capsules were found to contain "N-nitroso Prazosin impurity C” at levels that exceeded what the FDA considers acceptable for human consumption. This impurity is classified as a potential carcinogen when consumed over time.

The FDA classified both recalls as Class II, meaning the products could cause temporary or medically reversible health problems.

The medication is commonly used to treat high blood pressure and is sometimes prescribed for those who experience nightmares related to post-traumatic stress disorder.

Which blood pressure medications are recalled?

Teva Pharmaceuticals USA Recall

Distributed by: Teva Pharmaceuticals USA, Inc., Parsippany, New Jersey
Recall numbers: D-0104-2026, D-0105-2026, D-0106-2026
Products and quantities:
- Prazosin Hydrochloride Capsules USP, 1 mg
  - Multiple lots: Expiring October 2025–August 2026
  - Quantity recalled: 181,659 bottles
- Prazosin Hydrochloride Capsules USP, 2 mg
  - Multiple lots: Expiring October 2025–February 2028
  - Quantity recalled: 291,512 bottles
- Prazosin Hydrochloride Capsules USP, 5 mg
  - Multiple lots: Expiring November 2025–February 2027
  - Quantity recalled: 107,673 bottles
  - Total recalled by Teva: More than 580,000 bottles

What should patients do?

Do not stop taking your medication without first consulting your doctor. Suddenly discontinuing blood pressure medication can raise your risk of serious complications.

For Class II and III recalls, the FDA notes that patients can usually continue taking their medication unless the manufacturer provides different instructions. In some cases, stopping treatment may pose a greater risk than continuing to use the recalled product.

If your medication is affected:

Contact your doctor or pharmacist for specific guidance.
Return recalled medication to your pharmacy for proper disposal.
Report any side effects or quality issues through the FDA’s Medwatch Adverse Event Reporting Program.

How to check with your pharmacy about a drug recall

Under the FDA’s Drug Supply Chain Security Act (DSCSA), pharmacies and distributors must maintain detailed tracking records for medications at the package level. However, once drugs are repackaged into single doses, tracking becomes more complex because those smaller containers often lack the original lot numbers or serial codes. In these cases, the pharmacy or repackaging facility must keep records that link each unit dose back to the manufacturer’s original lot number and expiration date.

If you aren’t sure whether your medication is part of a recall, contact your pharmacy or health care provider. They can check their internal tracking system to confirm whether your medication came from an affected lot.

%{postComment}%